SCHEMBL6156765

SCHEMBL6156765

O=C(CC(O)CC(=O)OCc1ccc(Cl)cc1)OCc1ccc(Cl)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.49
MAPT P10636 3/20 0.49
KMT2A Q03164 3/20 0.49
POLB P06746 1/20 0.49
ALDH1A1 P00352 5/20 0.47
GAA P10253 2/20 0.47
NPSR1 Q6W5P4 3/20 0.44
L3MBTL1 Q9Y468 3/20 0.44
MMP2 P08253 3/20 0.44
MMP1 P03956 1/20 0.44
MMP9 P14780 1/20 0.44
MMP12 P39900 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
HTT P42858 2/20 0.43
MAPK1 P28482 2/20 0.43
USP2 O75604 1/20 0.43
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8622367 0.86 ALDH1A1 (0.48) MEN1MAPTKMT2APOLBALDH1A1
SCHEMBL6153385 0.82 KMT2A (0.49) MEN1MAPTKMT2AALDH1A1L3MBTL1
SCHEMBL6154533 0.82 KMT2A (0.46) MEN1MAPTKMT2AALDH1A1L3MBTL1
SCHEMBL6153568 0.81 ALDH1A1 (0.63) KMT2AALDH1A1L3MBTL1MMP9MAPK1
SCHEMBL8954202 0.81 MEN1 (0.58) MEN1MAPTKMT2APOLBALDH1A1
SCHEMBL27881634 0.80 SLC15A1 (0.50) MEN1MAPTKMT2APOLBALDH1A1
SCHEMBL27840116 0.80 SLC15A1 (0.50) MEN1MAPTKMT2APOLBALDH1A1
SCHEMBL3924805 0.79 MEN1 (0.53) MEN1MAPTKMT2APOLBALDH1A1
SCHEMBL6154504 0.79 ALDH1A1 (0.51) KMT2APOLBALDH1A1GAAL3MBTL1
Hydrochloric Acid SCHEMBL14482107 0.79 SLC15A1 (0.49) MEN1MAPTKMT2APOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050119341-A1 3-substituted oxyglutaric diester compound, optically active 3-substituted oxyglutaric monoester compound, and processes for producing these UBE INDUSTRIES, LTD. (JP) 2005-06-02 US disclosed
EP-1500642-A1 3-SUBSTITUTED OXYGLUTARIC DIESTER COMPOUND, OPTICALLY ACTIVE 3-SUBSTITUTED OXYGLUTARIC MONOESTER COMPOUND, AND PROCESSES FOR PRODUCING THESE Ube Industries, Ltd. (JP) 2005-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050119341-A1 3-substituted oxyglutaric diester compound, optically active 3-substituted oxyglutaric monoester compound, and processes for producing these OGDH, GLUL, ADSL MEN1 2902/4885MAPT 3886/4885KMT2A 2290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.